...
首页> 外文期刊>Pathogens and disease[electronic] >Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli
【24h】

Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli

机译:天然抗菌剂subtilosin和月桂酰胺精氨酸乙酯协同传统抗生素克林霉素和甲硝唑生物膜鞘突加德纳菌属,但不反对健康阴道乳酸杆菌的生物膜

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to evaluate the ability of clindamycin and metronidazole to synergize with natural antimicrobials against biofilms of bacterial vaginosis (BV)-associated Gardnerella vaginalis. Minimum bactericidal concentrations for biofilm cells (MBCs-B) were determined for each antimicrobial. The MBCs-B of lauramide arginine ethyl ester (LAE), subtilosin, clindamycin and metronidazole were 50, 69.5, 20 and 500 mu g mL(-1), respectively. A checkerboard assay and isobologram were used to analyze the type of interactions between these antimicrobials. The combination of metronidazole with natural antimicrobials did not inhibit planktonic lactobacilli. Clindamycin with either LAE or with subtilosin was inhibitory for planktonic but not for biofilm-associated lactobacilli. All tested antimicrobial combinations were inhibitory for BV-associated Mobiluncus curtisii and Peptostreptococcus anaerobius. LAE and subtilosin synergized with clindamycin and metronidazole against biofilms of G. vaginalis but not biofilm-associated vaginal lactobacilli. The biofilms of BV-associated pathogens can be controlled by synergistically acting combinations of conventional antibiotics and natural antimicrobials which will help better management of current antibiotics, especially considering robust bacterial resistance. Our findings create a foundation for a new strategy in the effective control of vaginal infections.
机译:本研究的目的是评估克林霉素和甲硝唑治疗的能力协同天然抗菌剂生物膜的细菌性阴道炎(BV)相关联加德纳菌属鞘突。浓度对生物膜细胞(MBCs-B)确定每个抗菌素。subtilosin月桂酰胺精氨酸乙酯(莱城),克林霉素和甲硝唑50,69.5,20和500亩g毫升(1),分别。分析和isobologram被用于分析这些类型的相互作用抗菌素。天然抗菌剂不抑制浮游乳酸杆菌。莱城或subtilosin被抑制浮游biofilm-associated但不是乳酸杆菌。抑制了BV-associated组合Mobiluncus curtisii and Peptostreptococcusanaerobius。克林霉素和甲硝唑对生物膜g .养狐场但不是biofilm-associated阴道乳酸杆菌。病原体可以通过协同控制表演传统抗生素的组合和天然抗菌素这将帮助更好目前抗生素的管理,尤其是考虑到强劲的细菌耐药性。结果创建一个新的策略的基础在阴道感染的有效控制。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号